Analysts raised their predictions for Carlsmed after the company reported strong sales and losses last quarter.

Nov 11, 2026, 11:33 AM ETResultsRead the original at Benzinga

Good for CARL

Sales beat estimates, its per-share loss was smaller than expected, and it raised its 2026 sales forecast. It still reported a loss, but stronger sales and the higher forecast point to improvement.

CARL · Carlsmed, Inc.

AI read · Good for CARL

The AI's read

Its surgeon user base grew by more than 60%, and sales grew 65% from a year earlier. The company also secured new inpatient CMS reimbursement for its aprevo procedure, which may broaden access. Carlsmed still lost money, so stronger sales do not yet show a profitable business.

Get alerts for CARL

Follow Carlsmed, Inc. (CARL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CARL

Free on the App Store and Google Play, or on the web.